Smart battles: immunosuppression versus immunomodulation in the inflammatory RMDs.

Isaacs, John D; Burmester, Gerd R

Isaacs, John D; Burmester, Gerd R.

Isaacs JD; Translational and Clinical Research Institute and Musculoskeletal Unit, Newcastle University and Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK john.isaacs@newcastle.ac.uk.
Burmester GR; Department of Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany.

Ann Rheum Dis ; 79(8): 991-993, 2020 08.

Article in English | MEDLINE | ID: covidwho-1383495

Subject(s)

Coronavirus Infections/drug therapy; Immunomodulation; Immunosuppression Therapy/methods; Pneumonia, Viral/drug therapy; Rheumatic Diseases/drug therapy; Betacoronavirus; COVID-19; Coronavirus Infections/immunology; Humans; Immunomodulation/immunology; Immunosuppression Therapy/adverse effects; Pandemics; Pneumonia, Viral/immunology; Rheumatic Diseases/immunology; SARS-CoV-2; COVID-19 Drug Treatment

Keywords

biological therapy; cytokines; therapeutics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Rheumatic Diseases / Immunosuppression Therapy / Coronavirus Infections / Immunomodulation Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2020 Document Type: Article Affiliation country: ANNRHEUMDIS-2020-218019

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google